Breda Rode

Title: Breda Rode: Innovator in Cholesterol Biosynthesis Inhibition

Introduction

Breda Rode is a notable inventor based in Kamnik, Slovenia. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit cholesterol biosynthesis. His work is crucial for addressing health issues related to hypercholesterolemia and hyperlipemia.

Latest Patents

Breda Rode holds a patent for "Derivatives of pyridilethanol (phenylethyl) amines as inhibitors of cholesterol biosynthesis, process for their preparation and pharmaceutical compositions containing them." This patent describes novel derivatives of pyridilethanol amines that serve as ligands of sigma receptors, effectively inhibiting cholesterol biosynthesis. The most effective compound identified in his research is 1-(d-pyridyl)-2-(N-(2-(3,4-dicholorophenyl)ethyl-N-propylamino)ethanol in the form of dihydrobromide salt (signature BK-35, 2HBr), which has shown the greatest lowering of cholesterol levels.

Career Highlights

Breda Rode is associated with Lek Pharmaceuticals D.d., a prominent company in the pharmaceutical industry. His innovative work has positioned him as a key figure in the development of new therapeutic agents aimed at managing cholesterol levels in patients.

Collaborations

Breda has collaborated with several professionals in his field, including Damjana Rozman and Klementina Fon Tacer. These collaborations have enhanced the research and development of effective pharmaceutical solutions.

Conclusion

Breda Rode's contributions to the field of cholesterol biosynthesis inhibition highlight his role as an important inventor in the pharmaceutical industry. His innovative approaches and collaborations continue to pave the way for advancements in treating cholesterol-related health issues.